Insider Selling: Braze (NASDAQ:BRZE) CAO Sells $60,803.36 in Stock

Braze, Inc. (NASDAQ:BRZEGet Free Report) CAO Pankaj Malik sold 2,344 shares of the stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $25.94, for a total transaction of $60,803.36. Following the sale, the chief accounting officer owned 66,930 shares in the company, valued at approximately $1,736,164.20. The trade was a 3.38% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Braze Stock Up 5.4%

Shares of NASDAQ BRZE opened at $26.90 on Friday. The firm has a market cap of $2.84 billion, a P/E ratio of -26.63 and a beta of 1.10. Braze, Inc. has a twelve month low of $23.91 and a twelve month high of $48.33. The company has a 50 day moving average of $27.17 and a 200 day moving average of $32.04.

Braze (NASDAQ:BRZEGet Free Report) last posted its earnings results on Thursday, June 5th. The company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.02. Braze had a negative return on equity of 18.89% and a negative net margin of 16.76%.The business had revenue of $162.06 million during the quarter, compared to analyst estimates of $158.60 million. During the same quarter last year, the company earned ($0.05) EPS. The company’s quarterly revenue was up 19.6% compared to the same quarter last year. Braze has set its FY 2026 guidance at 0.150-0.180 EPS. Q2 2026 guidance at 0.020-0.030 EPS. As a group, equities analysts expect that Braze, Inc. will post -0.98 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently commented on the company. Mizuho started coverage on Braze in a report on Thursday, July 24th. They issued an “outperform” rating and a $40.00 price objective for the company. Barclays reduced their price target on shares of Braze from $43.00 to $35.00 and set an “overweight” rating for the company in a research note on Monday, August 18th. Cantor Fitzgerald began coverage on shares of Braze in a report on Tuesday, June 3rd. They set an “overweight” rating and a $45.00 price objective for the company. Macquarie lowered their price objective on shares of Braze from $40.00 to $35.00 and set a “neutral” rating on the stock in a research report on Friday, June 6th. Finally, Raymond James Financial cut their target price on shares of Braze from $48.00 to $43.00 and set an “outperform” rating for the company in a research report on Friday, June 6th. Twenty analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $44.90.

Read Our Latest Research Report on Braze

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in BRZE. Vanguard Group Inc. lifted its position in shares of Braze by 5.3% during the 1st quarter. Vanguard Group Inc. now owns 8,911,907 shares of the company’s stock valued at $321,542,000 after buying an additional 447,746 shares in the last quarter. T. Rowe Price Investment Management Inc. raised its stake in Braze by 2.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,693,357 shares of the company’s stock worth $112,798,000 after acquiring an additional 63,000 shares during the period. Alliancebernstein L.P. lifted its holdings in Braze by 28.8% during the second quarter. Alliancebernstein L.P. now owns 2,320,171 shares of the company’s stock valued at $65,197,000 after purchasing an additional 518,103 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Braze by 2.8% during the second quarter. JPMorgan Chase & Co. now owns 2,316,234 shares of the company’s stock valued at $65,086,000 after purchasing an additional 64,025 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Braze by 121.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,197,407 shares of the company’s stock worth $92,028,000 after purchasing an additional 1,203,149 shares during the period. 90.47% of the stock is currently owned by institutional investors.

Braze Company Profile

(Get Free Report)

Braze, Inc operates a customer engagement platform that provides interactions between consumers and brands worldwide. The company offers Braze software development kits that automatically manage data ingestion and deliver mobile and web notifications, in-application/in-browser interstitial messages, and content cards; REST API that can be used to import or export data or to trigger workflows between Braze and brands' existing technology stacks; Partner Data Integrations, which allow brands to sync user cohorts from partners; Data Transformation, in which brands can programmatically sync and transform user data; and Braze Cloud Data Ingestion that enables brands to harness their customer data.

Featured Stories

Insider Buying and Selling by Quarter for Braze (NASDAQ:BRZE)

Receive News & Ratings for Braze Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braze and related companies with MarketBeat.com's FREE daily email newsletter.